Gastroparesis
Gastroenterology·MeSH: Gastroparesis
Prevalence
30.0 / 100K
7 drugs in development·6 companies·4 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| gimoti | Evoke Pharma Inc (EVOK) |
Phase 3(2)
Phase 2(3)
Preclinical(1)
| Drug | Company |
|---|---|
| rm-131 | Allergan plc (AGN) |
Compare drugs
Frequently asked questions
How many drugs are in development for Gastroparesis?
BioSniper tracks 7 drugs in development for Gastroparesis across 6 companies.
How many clinical trials target Gastroparesis?
There are 4 clinical trials targeting Gastroparesis tracked by BioSniper.
What is the prevalence of Gastroparesis?
The estimated prevalence of Gastroparesis is approximately 30.0 per 100,000 population.
Deep-dive into Gastroparesis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis